Trials / Completed
CompletedNCT00269685
Comparison of Vasopressin and Other Pressors in Septic Shock
Comparative Prospective Study of Vasopressin and Catecholamine in Septic Shock
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Université de Sherbrooke · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the classical tactics in the treatment of septic shock (dopamine, noradrenalin and dobutamine) to the use of vasopressin as first choice pressor. Vasopressin seems to be an interesting alternative in the treatment of septic shock. To this date, available studies have showed that it could correct hyperkinetic syndrome and vasoplegia in septic shocks without noticeable side effect. It as been demonstrated that vasopressin improves renal function, as no effect on digestive organs and as no metabolic effect.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | vasopressin |
Timeline
- Start date
- 2000-07-01
- First posted
- 2005-12-23
- Last updated
- 2006-05-29
Source: ClinicalTrials.gov record NCT00269685. Inclusion in this directory is not an endorsement.